The stock's fall snapped a four-day winning streak.

Abbott Laboratories (ABT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Fintel reports that on October 8, 2024, Oppenheimer initiated coverage of Abbott Laboratories (NYSE:ABT) with a Outperform ...

Abbott Laboratories (ABT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

On the non-MedTech side, Nutrition and Diagnostics sales comps will ease over the next few years, driving revenue growth with ...

Abbott Laboratories's ABT short percent of float has risen 4.05% since its last report. The company recently reported that it ...

Somerset Trust Co lowered its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.6% in the 3rd quarter, ...

Mattson Financial Services LLC cut its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 0.7% in the 3rd quarter, ...

CNBC’s Jim Cramer explains why he is keeping an eye on shares of Abbott Labs.

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

Abbott Laboratories reported it achieved new major milestones to support the company's growing suite of pulsed field ablation (PFA) solutions in electrophysiology: early completion of enrollment in ...

RBC Capital analyst Shagun Singh raised the firm’s price target on Abbott to $130 from $125 and keeps an Outperform rating on ...